Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Looking Beyond Nursing Education Practice to Include Sustainable Health-Care Systems Processes.

Autor: Roden JE, Lewis T

Publikováno v: Creative nursing [Creat Nurs] 2021 Nov 01; Vol. 27 (4), pp. 251-256.

Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.

Autor: Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Stevenson PA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Frayo SL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Oliveira GR; Department of Radiology, Harvard Medical School, MGH Hospital, Boston, MA, USA., Smith SD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Green DJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Roden JE; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Wood BL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematopathology, Department of Laboratory Medicine, University of Washington, Seattle, WA, USA., Press OW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2017 Feb; Vol. 176 (4), pp. 583-590. Date of Electronic Publication: 2017 Jan 05.

Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.

Autor: Onishi M; Department of Medicine, University of Washington, Seattle, WA, USA., Graf SA; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Holmberg L; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Behnia S; Department of Radiology, University of Washington, Seattle, WA, USA., Shustov AR; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Schiavo K; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Philip M; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Libby EN; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Cassaday RD; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Pagel JM; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Roden JE; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Maloney DG; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Green DJ; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Till BG; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Press OW; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Smith SD; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Gopal AK; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.

Publikováno v: Hematological oncology [Hematol Oncol] 2015 Dec; Vol. 33 (4), pp. 187-91. Date of Electronic Publication: 2014 Sep 18.